BoomerangFX, DrFirst Launch E-Prescribing for Aesthetic Medicine Practices
The secure e-prescribing platform complies with requirements for electronic prescribing for controlled substances and state prescription drug monitoring programs.
The secure e-prescribing platform complies with requirements for electronic prescribing for controlled substances and state prescription drug monitoring programs.
Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.